Vestmark Advisory Solutions »

Crispr Therapeutics shares owned by Vestmark Advisory Solutions

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Vestmark Advisory Solutions from 13F filings

Historical chart of Vestmark Advisory Solutions investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Vestmark Advisory Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Vestmark Advisory Solutions

Quarter filed Position value Share count Share price at filing
2025-09-30 $16M 239k 64.81
2025-06-30 $24M 485k 48.64
2025-03-31 $7.7M 225k 34.03
2024-12-31 $17M 244k 68.16
2024-09-30 $8.2M 174k 46.98
2024-06-30 $11M 198k 54.01
2024-03-31 $17M 250k 68.16
2023-12-31 $11M 173k 62.60